Alagebrium-chloride-ALT711-DataSheet-生命科学试剂-MedChemExpress_第1页
Alagebrium-chloride-ALT711-DataSheet-生命科学试剂-MedChemExpress_第2页
Alagebrium-chloride-ALT711-DataSheet-生命科学试剂-MedChemExpress_第3页
Alagebrium-chloride-ALT711-DataSheet-生命科学试剂-MedChemExpress_第4页
全文预览已结束

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEAlagebrium chlorideCat. No.: HY-106024BCAS No.: 341028-37-3Synonyms: ALT711分式: CHClNOS分量: 267.77作靶点: Others作通路: Others储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性数据体外实验 H2O : 50 mg/mL (186.73 mM; Nee

2、d ultrasonic)DMSO : 25 mg/mL (93.36 mM)* means soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制备储备液1 mM 3.7345 mL 18.6727 mL 37.3455 mL5 mM 0.7469 mL 3.7345 mL 7.4691 mL10 mM 0.3735 mL 1.8673 mL 3.7345 mL请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存式和期限。体内实验请根据您的实验动物和给药式选择适当的溶解案,

3、配制前请先配制澄清的储备液,再依次添加助溶剂(为保证实验结果的可靠性,体内实验的作液,建议您现现配,当天使;澄清的储备液可以根据储存条件,适当保存;以下溶剂前的百分 指该溶剂在您配制终溶液中的体积占):1. 请依序添加每种溶剂: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL (9.34 mM); Clear solution2. 请依序添加每种溶剂: 10% DMSO 90% corn oil1/3 Master of Small Molecules 您边的抑制剂师www.MedChemESolubility: 2.5 mg/

4、mL (9.34 mM); Clear solutionBIOLOGICAL ACTIVITY物活性 Alagebrium chloride种晚期糖基化终产物 (AGE) 抑制剂。IC50 & Target AGE 1体外研究 Alagebrium chloride is an advanced glycation end product (AGE) inhibitor. Endothelial cell (EC) proliferationis increased for all groups receiving Alagebrium (ALT-711), particularly when

5、 seeded on matrix from the AAoof obese (ZO) and diabetic (ZD) rats 2.体内研究 Blood pressure is not affected by treatment with Alagebrium. In diabetic RAGE apoE double-KO mice,treatment with Alagebrium is associated with a modest reduction in renal mass and reduces hyperfiltrationcompare with nontreated

6、 mice. Treatment with Alagebrium in diabetic RAGE apoE double-KO mice isassociated with a further reduction in glomerular collagen IV levels, approaching levels observed in controlmice 1. Body weight, heart rate (HR), and mean blood pressure (BP) are similar in Zucker lean (ZL), obese(ZO), and diabe

7、tic (ZD) groups in the absence or presence of Alagebrium (ALT-711). Alagebrium increasesblood flow (BF) in ZO rats but reduces distal vascular resistance in ZD rats. A decrease in neointimalhyperplasia (NH) intrastrut thickness as a function of local radius is found in all groups with Alagebriumtrea

8、tment. A significant increase in TGF- expression is also found in the AAo of ZL rats treated withAlagebrium 2.PROTOCOLCell Assay 2 Human aortic endothelial cells (HAECs) are seeded on decellularized matrices derived from the abdominalaorta (AAo) of Zucker lean (ZL), obese (ZO), and diabetic (ZD) rat

9、s with or without Alagebrium (ALT-711) (20g/mL in Dulbeccos PBS with 1 antibiotic-antimycotic). Experiments are performed when cells reach 80 to90% confluence. Flow chambers are sealed to the HAEC monolayers via a vacuum network. Flow is drivenby a Masterflex L/S peristaltic pump in a humidified cha

10、mber heated to 37C for 4 h. Leibovitz-15 medium,supplemented with 10% FBS, endothelial BulletKit, and 1 antibiotic-antimycotic solution, is used as the flowmedium to maintain pH in the absence of CO2 2.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Ani

11、mal RAGE apoE mice are randomized to be treated with Alagebrium (1 mg/kg/day by gavage), or no treatmentAdministration 1 (n=20/group). After 20 weeks of diabetes, mice are placed into individual metabolic cages for 24 h and urineis collected. Body weight as well as fluid and food intake are recorded

12、. Urinary albumin excretion is estimatedin urine samples by a mouse albumin enzyme-linked immunosorbent assay (ELISA) kit according to the kitprotocol. Urinary and serum creatinine concentrations are measured by high-performance liquidchromatography (HPLC). Systolic blood pressure is assessed by a n

13、oninvasive tail cuff method in consciousmice at the end of the study 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.2/3 Master of Small Molecules 您边的抑制剂师www.MedChemE户使本产品发表的科研献 Am J Transl Res. 2019 Mar 15;11(3):1569-1580.See more customer validation

14、s on HYPERLINK / www.MedChemEREFERENCES1. Watson AM, et al. Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGEactivation in diabeticapolipoprotein E knockout mice. Diabetes. 2012 Aug;61(8):2105-13.2. Wang H, et al. Alagebrium inhibits neointimal hyperplasia and restores distributions of wall shear stress by reducing downstreamvascular resistance in obese and diabetic rats. Am J Physiol Heart Circ Physiol. 2015 Oct;

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论